CNBX Pharmaceuticals, Inc. (CNBX)
0.0002
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CNBX Pharmaceuticals Total Liabilities (Quarterly) : 2.672M for May 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 2.672M |
| February 28, 2026 | 2.548M |
| November 30, 2025 | 2.584M |
| August 31, 2025 | 2.515M |
| May 31, 2025 | 2.556M |
| February 28, 2025 | 2.621M |
| November 30, 2024 | 2.537M |
| August 31, 2024 | 2.511M |
| May 31, 2024 | 2.534M |
| February 29, 2024 | 2.522M |
| November 30, 2023 | 2.482M |
| August 31, 2023 | 2.516M |
| May 31, 2023 | 2.572M |
| February 28, 2023 | 2.474M |
| November 30, 2022 | 2.584M |
| August 31, 2022 | 2.444M |
| May 31, 2022 | 2.148M |
| February 28, 2022 | 1.786M |
| November 30, 2021 | 1.493M |
| August 31, 2021 | 1.273M |
| May 31, 2021 | 1.47M |
| February 28, 2021 | 1.184M |
| November 30, 2020 | 0.4427M |
| August 31, 2020 | 0.4548M |
| May 31, 2020 | 0.4301M |
| Date | Value |
|---|---|
| February 29, 2020 | 0.4196M |
| November 30, 2019 | 0.4405M |
| August 31, 2019 | 0.4389M |
| May 31, 2019 | 0.4541M |
| February 28, 2019 | 0.3762M |
| November 30, 2018 | 0.4127M |
| August 31, 2018 | 0.5394M |
| May 31, 2018 | 0.5233M |
| February 28, 2018 | 0.4748M |
| November 30, 2017 | 0.6398M |
| August 31, 2017 | 0.6991M |
| May 31, 2017 | 0.5862M |
| February 28, 2017 | 0.7695M |
| November 30, 2016 | 0.5134M |
| August 31, 2016 | 0.4912M |
| May 31, 2016 | 0.4914M |
| February 29, 2016 | 0.4825M |
| November 30, 2015 | 0.1205M |
| August 31, 2015 | 0.3383M |
| May 31, 2015 | 0.2033M |
| February 28, 2015 | 0.097M |
| November 30, 2014 | 0.0785M |
| August 31, 2014 | |
| May 31, 2014 | 0.0038M |
| February 28, 2014 | 0.051M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
| Definium Therapeutics, Inc. | 194.22M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0128M |
| Shareholders Equity (Quarterly) | -2.660M |
| Debt to Equity Ratio | -0.4388 |
| Current Ratio | 0.0048 |
| Net Debt Paydown Yield | 15.69% |